Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies are pulling their stocks in completely opposite directions. Which move looks smarter…